GLOW 70

Glow:

≥99% Purity, HLPC.

Aliquot injectable vials fully sterilized

Shipped as Lyophilized Powder

BPC-157:
A stable gastric pentadecapeptide that accelerates angiogenesis, fibroblast migration, and epithelial regeneration through modulation of VEGFR2, FAK–paxillin, and nitric oxide pathways. Preclinical data indicate enhanced healing of tendons, muscles, and intestinal tissues.

TB-500 (Thymosin Beta-4):
A 43-amino acid peptide that binds actin and facilitates tissue repair by promoting cell migration, angiogenesis (through VEGF upregulation), and anti-inflammatory activity. It mobilizes progenitor cells and supports regeneration of cardiac, dermal, and connective tissues.

GHK-Cu:
A copper-chelating tripeptide (glycyl-L-histidyl-L-lysine) known to enhance wound repair, collagen formation, and hair follicle growth. It influences gene expression associated with tissue remodeling and exerts antioxidant and anti-inflammatory effects through regulation of TGF-β and metalloproteinases.

Synergistic Potential:
Research combining BPC-157, TB-500, and GHK-Cu suggests additive or synergistic effects in tissue regeneration and inflammation control by targeting multiple reparative mechanisms:

Angiogenesis: TB-500 and BPC-157 activate VEGF-driven vascular growth, while GHK-Cu promotes endothelial cell proliferation.
Cell migration and matrix remodeling: TB-500 enhances actin dynamics and cellular motility; BPC-157 and GHK-Cu stimulate fibroblast activity and extracellular matrix synthesis.

Anti-inflammatory effects: All three peptides reduce oxidative stress and modulate cytokine-mediated inflammation, potentially accelerating recovery from chronic or complex injuries.